<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F325BF32-08AE-4621-8057-E5D6613B7308"><gtr:id>F325BF32-08AE-4621-8057-E5D6613B7308</gtr:id><gtr:name>St George's University of London</gtr:name><gtr:address><gtr:line1>Cranmer Terrace</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>SW17 0RE</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/BEB10C4F-5479-4941-B0B4-0CAD06381596"><gtr:id>BEB10C4F-5479-4941-B0B4-0CAD06381596</gtr:id><gtr:name>Veterinary Laboratories Agency</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/68F78F03-B2B0-4B8E-AB8D-02362018AD72"><gtr:id>68F78F03-B2B0-4B8E-AB8D-02362018AD72</gtr:id><gtr:name>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/02ECE3B0-F864-4593-BCE9-348E204E2058"><gtr:id>02ECE3B0-F864-4593-BCE9-348E204E2058</gtr:id><gtr:name>MRC National Inst for Medical Research</gtr:name><gtr:address><gtr:line1>The Ridgeway</gtr:line1><gtr:line2>Mill Hill</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>NW7 1AA</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/02ECE3B0-F864-4593-BCE9-348E204E2058"><gtr:id>02ECE3B0-F864-4593-BCE9-348E204E2058</gtr:id><gtr:name>MRC National Inst for Medical Research</gtr:name><gtr:address><gtr:line1>The Ridgeway</gtr:line1><gtr:line2>Mill Hill</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>NW7 1AA</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F325BF32-08AE-4621-8057-E5D6613B7308"><gtr:id>F325BF32-08AE-4621-8057-E5D6613B7308</gtr:id><gtr:name>St George's University of London</gtr:name><gtr:address><gtr:line1>Cranmer Terrace</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>SW17 0RE</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/BEB10C4F-5479-4941-B0B4-0CAD06381596"><gtr:id>BEB10C4F-5479-4941-B0B4-0CAD06381596</gtr:id><gtr:name>Veterinary Laboratories Agency</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/68F78F03-B2B0-4B8E-AB8D-02362018AD72"><gtr:id>68F78F03-B2B0-4B8E-AB8D-02362018AD72</gtr:id><gtr:name>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/D222D49C-F309-4199-A596-6C5ADEB39DBD"><gtr:id>D222D49C-F309-4199-A596-6C5ADEB39DBD</gtr:id><gtr:firstName>John</gtr:firstName><gtr:otherNames>William</gtr:otherNames><gtr:surname>McCauley</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U117585868"><gtr:id>9D0C906D-5BCE-40C4-BD6C-42F69C44887F</gtr:id><gtr:title>Host range determinants of influenza viruses</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U117585868</gtr:grantReference><gtr:abstractText>Three pandemics of influenza appeared in the twentieth century. In the 1918 pandemic an estimated 40 million people died from influenza infection. The associated mortality of the 1918 virus was remarkably high- the pandemics of 1957 and 1968 were associated with a much lower death rate. Pandemic influenza viruses emerge from influenza viruses found in avian species. The appearance over the last decade of H5N1 bird flu in Asia with its associated high human mortality rate highlights the risks of a new pandemic virus developing. The current H5N1 bird flu can infect humans but the infected individuals seem largely unable to transmit the infection to others. Should the virus acquire the ability to spread between individuals more efficiently, the possibility that a pandemic might occur is a major concern. We do not know all the factors that govern how an avian influenza virus gains the ability to infect and spread between humans. Avian influenza viruses vary in their ability to replicate in human cells in culture. We wish to understand why some avian influenza viruses are able to replicate efficiently in human cells but others are not, and we wish to discover the host factors that can limit the infection. We hope that with this knowledge we will be in a better position to anticipate the risks of avian influenza viruses jumping species to generate a pandemic virus.</gtr:abstractText><gtr:technicalSummary>Influenza viruses infect a variety of species; humans, horses and pigs are the main mammalian hosts of the virus in which infection is sustained. However avian species, particularly water fowl and gulls, harbour a very wide variety of influenza viruses and it is from the avian pool of influenza viruses that new pandemic strains of human influenza viruses arise. The currently ongoing infection of humans with H5N1 avian influenza viruses highlights the risk of infection from viruses normally present in the bird population to evolve into new pandemic human strains of virus. The factors that limit the infection of influenza viruses to their natural hosts are not clearly understood. It is known that the interaction between a virus particle and its receptor on the cell is a vital feature that limits host range of viruses but other factors following entry of virus into the cell also determine the outcome of infection. In this work we are studying aspects of host range restriction of avian influenza viruses that limit their ability to infect and propagate in mammalian cells. Using panels of cell lines that are defective in innate anti-viral responses to infection we are examining how these cells influence the ability of human and avian viruses to replicate productively. Additionally we wish to uncover which virus factors influence the differences. We are initially focussing on cells that are defective in the induction of interferon-beta and other genes similarly controlled by interferon regulatory factor 3 (IRF-3), and on cells that are defective for interferon signalling through defects in the Jak/Stat pathway of signal transduction. We hope to define some of the factors of the host-pathogen interaction that are critical for virus host range. The results from this work we hope will put us in a better position to assess the risk of an emerging avian influenza infection acquiring the ability to infect new host species.</gtr:technicalSummary><gtr:fund><gtr:end>2014-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2006-04-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>3636090</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Veterinary Laboratories Agency</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Within host variation in influenza viruses in infected poultry</gtr:description><gtr:id>5320923E-A658-4A99-9B37-74CCDD308FAD</gtr:id><gtr:impact>A publication : McCauley et al. PhilTrans. Roy. Soc, 2009 and an addtional submission is under consideration for publication.</gtr:impact><gtr:outcomeId>tnNcpvYPyFw-2</gtr:outcomeId><gtr:partnerContribution>This is an ongoing project fuinded by BBSRCThis is a BBSRC funded collaborative project with IAH, NIMR and VLA.</gtr:partnerContribution><gtr:piContribution>With the Institute for Animal Health and the Animal health Veterinary Laboratories Agency we have a BBSRC funded project to examine how avian influenza viruses might vary over the course of infection in different avian hosts.</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Human Immunology Unit</gtr:department><gtr:description>Animal Influenza characteristion</gtr:description><gtr:id>838094E4-FDC7-4643-9D2A-F87392E8330F</gtr:id><gtr:impact>Publications from collaborative work.</gtr:impact><gtr:outcomeId>BE50850CEB0-6</gtr:outcomeId><gtr:partnerContribution>We have a long term collaboration with the Institute fro Animal Health on influenza virus biology and on pestivirus biology We work closely with collaborators on influenza viruses and pestivirusesWe have a long term collaboration with the Veterinary Laboratories Agency on animal influenza viruses. We have joint BBSRC project grant funding.We have a long standing collaboration on animal influenza modellingWe collaborate on influenza virus transmission in experiential animals and field studies.Two collaborations have been set up. One with Dr. Ling Pei Ho to study how H5N1 avian influenza viruses replicate in wild-type and mice transgenic for aspects of innate immunity. The second collaboration is with Dr. Kirsten Luhn to provide advice and viruses for her studies on the replication of influenza viruses in cells of the immune system.</gtr:partnerContribution><gtr:piContribution>We have received funding on two BBSRC project grants from 2006. These were focussing on the transmission dynamics, pathogenicity, immune responses and modelling of influenza viruses in avian hosts. We collaborate on BBSRC funded projects on swine influenza infections in pigs and pig workers.</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Pirbright Institute</gtr:department><gtr:description>Within host variation in influenza viruses in infected poultry</gtr:description><gtr:id>FFFA739E-F4EF-4B24-971C-E2DD6BB760C9</gtr:id><gtr:impact>A publication : McCauley et al. PhilTrans. Roy. Soc, 2009 and an addtional submission is under consideration for publication.</gtr:impact><gtr:outcomeId>tnNcpvYPyFw-1</gtr:outcomeId><gtr:partnerContribution>This is an ongoing project fuinded by BBSRCThis is a BBSRC funded collaborative project with IAH, NIMR and VLA.</gtr:partnerContribution><gtr:piContribution>With the Institute for Animal Health and the Animal health Veterinary Laboratories Agency we have a BBSRC funded project to examine how avian influenza viruses might vary over the course of infection in different avian hosts.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>St George's University of London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Basic Medical Sciences</gtr:department><gtr:description>Animal Influenza characteristion</gtr:description><gtr:id>5B6DD631-BB40-47A7-952C-C735B60D034B</gtr:id><gtr:impact>Publications from collaborative work.</gtr:impact><gtr:outcomeId>BE50850CEB0-2</gtr:outcomeId><gtr:partnerContribution>We have a long term collaboration with the Institute fro Animal Health on influenza virus biology and on pestivirus biology We work closely with collaborators on influenza viruses and pestivirusesWe have a long term collaboration with the Veterinary Laboratories Agency on animal influenza viruses. We have joint BBSRC project grant funding.We have a long standing collaboration on animal influenza modellingWe collaborate on influenza virus transmission in experiential animals and field studies.Two collaborations have been set up. One with Dr. Ling Pei Ho to study how H5N1 avian influenza viruses replicate in wild-type and mice transgenic for aspects of innate immunity. The second collaboration is with Dr. Kirsten Luhn to provide advice and viruses for her studies on the replication of influenza viruses in cells of the immune system.</gtr:partnerContribution><gtr:piContribution>We have received funding on two BBSRC project grants from 2006. These were focussing on the transmission dynamics, pathogenicity, immune responses and modelling of influenza viruses in avian hosts. We collaborate on BBSRC funded projects on swine influenza infections in pigs and pig workers.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Veterinary Medicine</gtr:department><gtr:description>Animal Influenza characteristion</gtr:description><gtr:id>FADFB041-C1C8-46C9-A440-A769DE0515FC</gtr:id><gtr:impact>Publications from collaborative work.</gtr:impact><gtr:outcomeId>BE50850CEB0-5</gtr:outcomeId><gtr:partnerContribution>We have a long term collaboration with the Institute fro Animal Health on influenza virus biology and on pestivirus biology We work closely with collaborators on influenza viruses and pestivirusesWe have a long term collaboration with the Veterinary Laboratories Agency on animal influenza viruses. We have joint BBSRC project grant funding.We have a long standing collaboration on animal influenza modellingWe collaborate on influenza virus transmission in experiential animals and field studies.Two collaborations have been set up. One with Dr. Ling Pei Ho to study how H5N1 avian influenza viruses replicate in wild-type and mice transgenic for aspects of innate immunity. The second collaboration is with Dr. Kirsten Luhn to provide advice and viruses for her studies on the replication of influenza viruses in cells of the immune system.</gtr:partnerContribution><gtr:piContribution>We have received funding on two BBSRC project grants from 2006. These were focussing on the transmission dynamics, pathogenicity, immune responses and modelling of influenza viruses in avian hosts. We collaborate on BBSRC funded projects on swine influenza infections in pigs and pig workers.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Applied Mathematics and Theoretical Physics (DAMTP)</gtr:department><gtr:description>Animal Influenza characteristion</gtr:description><gtr:id>03D13C01-0AFC-4A95-B86E-9C2D11CF52A5</gtr:id><gtr:impact>Publications from collaborative work.</gtr:impact><gtr:outcomeId>BE50850CEB0-4</gtr:outcomeId><gtr:partnerContribution>We have a long term collaboration with the Institute fro Animal Health on influenza virus biology and on pestivirus biology We work closely with collaborators on influenza viruses and pestivirusesWe have a long term collaboration with the Veterinary Laboratories Agency on animal influenza viruses. We have joint BBSRC project grant funding.We have a long standing collaboration on animal influenza modellingWe collaborate on influenza virus transmission in experiential animals and field studies.Two collaborations have been set up. One with Dr. Ling Pei Ho to study how H5N1 avian influenza viruses replicate in wild-type and mice transgenic for aspects of innate immunity. The second collaboration is with Dr. Kirsten Luhn to provide advice and viruses for her studies on the replication of influenza viruses in cells of the immune system.</gtr:partnerContribution><gtr:piContribution>We have received funding on two BBSRC project grants from 2006. These were focussing on the transmission dynamics, pathogenicity, immune responses and modelling of influenza viruses in avian hosts. We collaborate on BBSRC funded projects on swine influenza infections in pigs and pig workers.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Pirbright Institute</gtr:department><gtr:description>Animal Influenza characteristion</gtr:description><gtr:id>BBC3D4A4-03C9-4CBC-83C4-F7D7A3103D60</gtr:id><gtr:impact>Publications from collaborative work.</gtr:impact><gtr:outcomeId>BE50850CEB0-1</gtr:outcomeId><gtr:partnerContribution>We have a long term collaboration with the Institute fro Animal Health on influenza virus biology and on pestivirus biology We work closely with collaborators on influenza viruses and pestivirusesWe have a long term collaboration with the Veterinary Laboratories Agency on animal influenza viruses. We have joint BBSRC project grant funding.We have a long standing collaboration on animal influenza modellingWe collaborate on influenza virus transmission in experiential animals and field studies.Two collaborations have been set up. One with Dr. Ling Pei Ho to study how H5N1 avian influenza viruses replicate in wild-type and mice transgenic for aspects of innate immunity. The second collaboration is with Dr. Kirsten Luhn to provide advice and viruses for her studies on the replication of influenza viruses in cells of the immune system.</gtr:partnerContribution><gtr:piContribution>We have received funding on two BBSRC project grants from 2006. These were focussing on the transmission dynamics, pathogenicity, immune responses and modelling of influenza viruses in avian hosts. We collaborate on BBSRC funded projects on swine influenza infections in pigs and pig workers.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Veterinary Laboratories Agency</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Animal Influenza characteristion</gtr:description><gtr:id>E75D6217-28B3-449C-A6BC-39C218A1F2C4</gtr:id><gtr:impact>Publications from collaborative work.</gtr:impact><gtr:outcomeId>BE50850CEB0-3</gtr:outcomeId><gtr:partnerContribution>We have a long term collaboration with the Institute fro Animal Health on influenza virus biology and on pestivirus biology We work closely with collaborators on influenza viruses and pestivirusesWe have a long term collaboration with the Veterinary Laboratories Agency on animal influenza viruses. We have joint BBSRC project grant funding.We have a long standing collaboration on animal influenza modellingWe collaborate on influenza virus transmission in experiential animals and field studies.Two collaborations have been set up. One with Dr. Ling Pei Ho to study how H5N1 avian influenza viruses replicate in wild-type and mice transgenic for aspects of innate immunity. The second collaboration is with Dr. Kirsten Luhn to provide advice and viruses for her studies on the replication of influenza viruses in cells of the immune system.</gtr:partnerContribution><gtr:piContribution>We have received funding on two BBSRC project grants from 2006. These were focussing on the transmission dynamics, pathogenicity, immune responses and modelling of influenza viruses in avian hosts. We collaborate on BBSRC funded projects on swine influenza infections in pigs and pig workers.</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Radio and Television interviews</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:id>FBB98372-4AD1-4E50-AC04-28C1ED1A0578</gtr:id><gtr:impact>Interviews on Radio 4 (approx 6 times), Radio 5, Radio Wales, the World Service, Sky TV, ITV News, BBC News, German TV, Ukraine TV, and many more

Public awareness of the H1N1 pandemic.</gtr:impact><gtr:outcomeId>002E01B7D47</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public Lecture, Kuala Lumpur, Malaysia</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>1E2C4A4A-769F-4919-817B-C3E3FA36DD60</gtr:id><gtr:impact>A public lecture was hosted as a public out-reach programme by a Bioinformatics company. The audience was the general public but was made up of Health Care Professionals. The topic was pandemic H1N1 influenza.

Awareness of the audience on the current state of knowledge on the H1N1 pandemic.</gtr:impact><gtr:outcomeId>6AA9CF7A37E</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentaion to European Medicines Ageny</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:id>A3ACD58E-CB9C-4CBD-8A13-517CD1201343</gtr:id><gtr:impact>The conclusions of the WHO Influenza Vaccine Selection meetings are presented to the European Medicicnes Agency for them to make a europesan-wide directive for the most appropraite influenza strain to be included in the following year's influenza vacine.

The impact is that the the recommednations that we (1 from NIMR and 8 others from other WHO Collboating Centres or Essential Reference labortories) reach as WHO advisors on the composition of influenza vaccines is put into practice.</gtr:impact><gtr:outcomeId>q92HeLydLx4</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2010,2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Television and Radio Interviews</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:id>DE7E2003-6062-4D68-A3BC-B1B100C38BC6</gtr:id><gtr:impact>Interviewed about H5N1 avian influenza virus

Increased public awareness of the risk of H5N1 influenza viruses in the UK and elsewhere</gtr:impact><gtr:outcomeId>280CB0CBB83</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2007,2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Television and Radio Interviews</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:id>9484CEF3-D1F7-4545-B8E6-6109364224C4</gtr:id><gtr:impact>Interview on GMTV and BBC Radio Northern Ireland about influenza vaccination and influenza vaccination policy

Increased information to the public on influenza vaccination.</gtr:impact><gtr:outcomeId>CDBBF6E4FFB</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2007,2009</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>446135</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC-Research Grant Award-2008</gtr:description><gtr:end>2013-07-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>7589095E-17D0-4057-9132-1D0758BE4668</gtr:id><gtr:outcomeId>17AB61138CB0</gtr:outcomeId><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>218147</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome-Research Grant-2008</gtr:description><gtr:end>2010-01-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>103D48F1-EAB6-467E-B137-114427F2A56A</gtr:id><gtr:outcomeId>0D1826954590</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>290189</gtr:amountPounds><gtr:country>Switzerland, Swiss Confederation</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>IFPMA-International Federation of Pharmaceutical Manufaturers&amp;amp;Associations/IFPMA</gtr:description><gtr:fundingOrg>International Federation of Pharmaceutical Manufacturers and Associations (IFPMA)</gtr:fundingOrg><gtr:id>1FF58C93-7654-4135-8249-759366B572B9</gtr:id><gtr:outcomeId>pHgLrPykLmE0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-06-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>WHO Influenza Vaccine Selection Committee</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>D52EE022-E489-4B74-996B-EDFF368B305D</gtr:id><gtr:impact>The WHO advisors reach a recommendation twice yearly on the optimal composition of influenza vaccines, once for the Northrn Hemisphere and once for the Southern Hemisphere influenza season.</gtr:impact><gtr:outcomeId>VpvQrmvQ849</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>WHO Influenza Training and Vaccine Selection, antiviral resistance monitoring.</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>595CC599-AA0E-4628-AF0F-FBDCA8759869</gtr:id><gtr:impact>Vaccine strain selection meetings results in updating the influenza vaccine on a twice-yearly basis. Training workshops lead to the development of the WHO Global Influenza Surveillance Network.</gtr:impact><gtr:outcomeId>47EA7CE696C</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Commons select committe on scientific advice and evidence in emergencies</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>3471DFD1-60F0-47F3-B825-BEB37AEBF1B2</gtr:id><gtr:impact>The committee was reviewing the UK management of the H1N1 influenza pandemic of 2009-2010. I contributed to the MRC section of the RCUK submission and I contributed as Director of the WHO Collaborating Centre for Reference and Research on Influenza a detailed reply on the international role UK played in the pandemic.</gtr:impact><gtr:outcomeId>dGJ9c2WcefJ</gtr:outcomeId><gtr:type>Gave evidence to a government review</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Sample of Haemagglutinin protein</gtr:description><gtr:id>023E685A-779D-41A3-BB48-5A4082767491</gtr:id><gtr:impact>Material supplied to commercial body under a Materials Use Licence</gtr:impact><gtr:outcomeId>86C411896FE</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Haemagglutinin</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>8F61E8EF-26B3-4588-A685-EB504F8B6700</gtr:id><gtr:title>Studies of an influenza A virus temperature-sensitive mutant identify a late role for NP in the formation of infectious virions.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/98a52e9048382f74d74ecbf651f456bc"><gtr:id>98a52e9048382f74d74ecbf651f456bc</gtr:id><gtr:otherNames>Noton SL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>760950656ED</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FF8C383E-E38A-46E2-A502-57AE79305B54</gtr:id><gtr:title>Development of a surveillance scheme for equine influenza in the UK and characterisation of viruses isolated in Europe, Dubai and the USA from 2010-2012.</gtr:title><gtr:parentPublicationTitle>Veterinary microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f52cf84fd9064586f4036b5cabe2b941"><gtr:id>f52cf84fd9064586f4036b5cabe2b941</gtr:id><gtr:otherNames>Woodward AL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0378-1135</gtr:issn><gtr:outcomeId>5457a2436f6761.70754713</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>66A79F1A-C1C5-4A82-A8AA-6083E24A3ABA</gtr:id><gtr:title>The relationship between mutation frequency and replication strategy in positive-sense single-stranded RNA viruses.</gtr:title><gtr:parentPublicationTitle>Proceedings. Biological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/76346e31a17dc509e61b98d0bf24f44b"><gtr:id>76346e31a17dc509e61b98d0bf24f44b</gtr:id><gtr:otherNames>Th?baud G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0962-8452</gtr:issn><gtr:outcomeId>1D79742D3C8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7F89B5A3-96C3-42B3-8B57-1C7164E7F8B8</gtr:id><gtr:title>Development of a reverse genetics system enabling the rescue of recombinant avian influenza virus A/Turkey/England/50-92/91 (H5N1).</gtr:title><gtr:parentPublicationTitle>Avian diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c5652c8423877f0379e8c1a80e1e87ae"><gtr:id>c5652c8423877f0379e8c1a80e1e87ae</gtr:id><gtr:otherNames>Howard W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0005-2086</gtr:issn><gtr:outcomeId>CDF7B17C3C2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>812853C8-B4E6-465E-898B-740B3AEEECE0</gtr:id><gtr:title>Selection of variant viruses during replication and transmission of H7N1 viruses in chickens and turkeys.</gtr:title><gtr:parentPublicationTitle>Virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/77f3a963e90bc06648b07ce0dd4612f0"><gtr:id>77f3a963e90bc06648b07ce0dd4612f0</gtr:id><gtr:otherNames>Iqbal M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0042-6822</gtr:issn><gtr:outcomeId>pm_15873_23_22944111</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DD0EC71B-DA6D-4811-914D-D757681108FE</gtr:id><gtr:title>A novel I221L substitution in neuraminidase confers high-level resistance to oseltamivir in influenza B viruses.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f94ede5326fdc10a9a00c4996598664e"><gtr:id>f94ede5326fdc10a9a00c4996598664e</gtr:id><gtr:otherNames>Escuret V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>5457a242734206.09983825</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E7DA0D65-A24C-4FC2-8650-E234D15E06B0</gtr:id><gtr:title>Infectivity and transmissibility of H9N2 avian influenza virus in chickens and wild terrestrial birds.</gtr:title><gtr:parentPublicationTitle>Veterinary research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/77f3a963e90bc06648b07ce0dd4612f0"><gtr:id>77f3a963e90bc06648b07ce0dd4612f0</gtr:id><gtr:otherNames>Iqbal M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0928-4249</gtr:issn><gtr:outcomeId>pm_15873_23_24134616</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C65550EE-B022-45F3-B25E-73AD09D53C14</gtr:id><gtr:title>Host genetics determine susceptibility to avian influenza infection and transmission dynamics.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/33aef8379f6c601007598cbdba16ca4f"><gtr:id>33aef8379f6c601007598cbdba16ca4f</gtr:id><gtr:otherNames>Ruiz-Hernandez R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>589ddd67695d59.49360640</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>38A3FAD7-1D82-4390-8FBB-B60933761260</gtr:id><gtr:title>Influenza virus survival in aerosols and estimates of viable virus loss resulting from aerosolization and air-sampling.</gtr:title><gtr:parentPublicationTitle>The Journal of hospital infection</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a75a267ef65956748d1b5fdaaa9a2c67"><gtr:id>a75a267ef65956748d1b5fdaaa9a2c67</gtr:id><gtr:otherNames>Brown JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0195-6701</gtr:issn><gtr:outcomeId>56d97673e22811.67571383</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5760B02B-992E-46D6-A238-FD91EA1EA134</gtr:id><gtr:title>The NPro product of bovine viral diarrhea virus inhibits DNA binding by interferon regulatory factor 3 and targets it for proteasomal degradation.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/89e2516c3a1b5ae8f9ca24fa778c9925"><gtr:id>89e2516c3a1b5ae8f9ca24fa778c9925</gtr:id><gtr:otherNames>Hilton L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>FF7586F88FE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E92C6BE9-5755-40AA-924B-FA5357191DA7</gtr:id><gtr:title>Strain-specific antiviral activity of iminosugars against human influenza A viruses.</gtr:title><gtr:parentPublicationTitle>The Journal of antimicrobial chemotherapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6a2f8e88b4d5243706965b6284b353bd"><gtr:id>6a2f8e88b4d5243706965b6284b353bd</gtr:id><gtr:otherNames>Hussain S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0305-7453</gtr:issn><gtr:outcomeId>5457a24174c2e2.57701619</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>792F07FD-9796-48F2-AF87-383500535EC5</gtr:id><gtr:title>Mouse Models of Influenza Infection with Circulating Strains to Test Seasonal Vaccine Efficacy.</gtr:title><gtr:parentPublicationTitle>Frontiers in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e2fa2000094fa04ed67ce189edff78b"><gtr:id>5e2fa2000094fa04ed67ce189edff78b</gtr:id><gtr:otherNames>Groves HT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1664-3224</gtr:issn><gtr:outcomeId>5a97da3b03d161.41842210</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>61B5183C-05FE-42AE-B480-25E5C556F9F0</gtr:id><gtr:title>M1-like monocytes are a major immunological determinant of severity in previously healthy adults with life-threatening influenza.</gtr:title><gtr:parentPublicationTitle>JCI insight</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f02aa2ebb10d042b908ae932541a85e1"><gtr:id>f02aa2ebb10d042b908ae932541a85e1</gtr:id><gtr:otherNames>Cole SL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2379-3708</gtr:issn><gtr:outcomeId>5a97da3a387197.35255376</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>401799D2-769F-4528-9FD4-844A6D87B099</gtr:id><gtr:title>Receptor binding by H10 influenza viruses.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0b4c687eb15e5d35fe0acbde92cd5152"><gtr:id>0b4c687eb15e5d35fe0acbde92cd5152</gtr:id><gtr:otherNames>Vachieri SG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>5457a24249bb47.12592225</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>24A54F6D-3429-4E91-B0CF-01134371F146</gtr:id><gtr:title>Integrating influenza antigenic dynamics with molecular evolution.</gtr:title><gtr:parentPublicationTitle>eLife</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/71fafd4a0e8082523ed381695139b36e"><gtr:id>71fafd4a0e8082523ed381695139b36e</gtr:id><gtr:otherNames>Bedford T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2050-084X</gtr:issn><gtr:outcomeId>5457a243219c47.06624312</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F120AA34-28C4-438B-A912-DCD9553824B4</gtr:id><gtr:title>Expression of the NS3 protease of cytopathogenic bovine viral diarrhea virus results in the induction of apoptosis but does not block activation of the beta interferon promoter.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4a384274198de42a1cd25ff784a5de08"><gtr:id>4a384274198de42a1cd25ff784a5de08</gtr:id><gtr:otherNames>Gamlen T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>07AA209533A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2337D30F-A513-4352-B64E-20EA35C4BDEA</gtr:id><gtr:title>Co-circulation of influenza A virus strains and emergence of pandemic via reassortment: the role of cross-immunity.</gtr:title><gtr:parentPublicationTitle>Epidemics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2a1ffb256ea1f8a75f52592d7011a432"><gtr:id>2a1ffb256ea1f8a75f52592d7011a432</gtr:id><gtr:otherNames>Zhang XS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1878-0067</gtr:issn><gtr:outcomeId>5457a3959ea3e6.20210945</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8E283320-7503-4622-BB8F-2C5E72660348</gtr:id><gtr:title>Efficient synthesis of highly active phospha-isosteres of the influenza neuraminidase inhibitor oseltamivir.</gtr:title><gtr:parentPublicationTitle>ChemMedChem</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8839114230b49985244ce99dba391282"><gtr:id>8839114230b49985244ce99dba391282</gtr:id><gtr:otherNames>Carbain B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1860-7179</gtr:issn><gtr:outcomeId>C36854EF7D4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DD96212B-0227-4AA0-B6B1-750644C3E20E</gtr:id><gtr:title>The influenza virus protein PB1-F2 interacts with IKK? and modulates NF-?B signalling.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e16a44ca574b321d3fbce50cf405e095"><gtr:id>e16a44ca574b321d3fbce50cf405e095</gtr:id><gtr:otherNames>Reis AL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_15873_23_23704945</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>05C7B8D9-BF94-4C56-9FA7-74F6C2C4EF62</gtr:id><gtr:title>Identification of Low- and High-Impact Hemagglutinin Amino Acid Substitutions That Drive Antigenic Drift of Influenza A(H1N1) Viruses.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/64b6d3888aa253092661ec6f881fc031"><gtr:id>64b6d3888aa253092661ec6f881fc031</gtr:id><gtr:otherNames>Harvey WT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>589ddd67c44ad3.35856049</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D0793739-7BF7-4E93-8CD9-E14048D20C3C</gtr:id><gtr:title>Virus pathotype and deep sequencing of the HA gene of a low pathogenicity H7N1 avian influenza virus causing mortality in Turkeys.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/77f3a963e90bc06648b07ce0dd4612f0"><gtr:id>77f3a963e90bc06648b07ce0dd4612f0</gtr:id><gtr:otherNames>Iqbal M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5457a2434af562.95708615</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DACCCF96-FFFF-4C98-800D-D067E8B6A188</gtr:id><gtr:title>Role of Neuraminidase in Influenza A(H7N9) Virus Receptor Binding.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d290ff09ba8140ec5ccbb1dcf0c460ca"><gtr:id>d290ff09ba8140ec5ccbb1dcf0c460ca</gtr:id><gtr:otherNames>Benton DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>5a97da3a0fac48.58847734</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>626AB5EC-108C-4CB9-B33B-FDC5EFB9E68B</gtr:id><gtr:title>Role of the B Allele of Influenza A Virus Segment 8 in Setting Mammalian Host Range and Pathogenicity.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/74d8440367138208e535cb9bf14b8b4c"><gtr:id>74d8440367138208e535cb9bf14b8b4c</gtr:id><gtr:otherNames>Turnbull ML</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>589ddd67404ad1.54749250</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>31AAB328-CFCA-4AAD-BB70-92716222D03E</gtr:id><gtr:title>NS1 proteins of avian influenza A viruses can act as antagonists of the human alpha/beta interferon response.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cfc541165003d5079dbe5df843fc5e19"><gtr:id>cfc541165003d5079dbe5df843fc5e19</gtr:id><gtr:otherNames>Hayman A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>E22FC80A8B3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>452166FC-7EDC-4CA2-9253-016972B57340</gtr:id><gtr:title>Dual Recognition Element Lateral Flow Assay Toward Multiplex Strain Specific Influenza Virus Detection.</gtr:title><gtr:parentPublicationTitle>Analytical chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5569830e53257fe80946d6339006dcb8"><gtr:id>5569830e53257fe80946d6339006dcb8</gtr:id><gtr:otherNames>Le TT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0003-2700</gtr:issn><gtr:outcomeId>5a97da3a60f372.22813032</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6226E587-18F9-4556-AFBA-EAE99C98D74D</gtr:id><gtr:title>An efficient genome sequencing method for equine influenza [H3N8] virus reveals a new polymorphism in the PA-X protein.</gtr:title><gtr:parentPublicationTitle>Virology journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1f59f9a1ca8d2a52d6bd442650547033"><gtr:id>1f59f9a1ca8d2a52d6bd442650547033</gtr:id><gtr:otherNames>Rash A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1743-422X</gtr:issn><gtr:outcomeId>5457a2419b9fb1.25128344</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DA57FBC6-3938-4A9C-B321-027CFBB617E4</gtr:id><gtr:title>Low frequency of the Mx allele for viral resistance predates recent intensive selection in domestic chickens.</gtr:title><gtr:parentPublicationTitle>Immunogenetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3e88640222be85e10da9dbaca4843f58"><gtr:id>3e88640222be85e10da9dbaca4843f58</gtr:id><gtr:otherNames>Balkissoon D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0093-7711</gtr:issn><gtr:outcomeId>D78E40C6BD9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3C1A67AD-5F62-449D-AE2F-14E0A902B1BC</gtr:id><gtr:title>Epidemiological, antigenic and genetic characteristics of seasonal influenza A(H1N1), A(H3N2) and B influenza viruses: basis for the WHO recommendation on the composition of influenza vaccines for use in the 2009-2010 northern hemisphere season.</gtr:title><gtr:parentPublicationTitle>Vaccine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f8d7f0af59a59e83c78c053634ae1e10"><gtr:id>f8d7f0af59a59e83c78c053634ae1e10</gtr:id><gtr:otherNames>Barr IG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0264-410X</gtr:issn><gtr:outcomeId>eYY1wzaE1Tu</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8B05BF81-9E00-4C66-9F9A-C3266571A307</gtr:id><gtr:title>Neuraminidase receptor binding variants of human influenza A(H3N2) viruses resulting from substitution of aspartic acid 151 in the catalytic site: a role in virus attachment?</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5360052184835a92de21a35704db22ac"><gtr:id>5360052184835a92de21a35704db22ac</gtr:id><gtr:otherNames>Lin YP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>HX3eDWmsQJX</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>42ABBAD9-CD24-4F7F-9B4E-B1FBA12E569A</gtr:id><gtr:title>Focused antibody response to influenza linked to antigenic drift.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7d699e537f6136ee6954dd5ce72f6d81"><gtr:id>7d699e537f6136ee6954dd5ce72f6d81</gtr:id><gtr:otherNames>Huang KY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0021-9738</gtr:issn><gtr:outcomeId>56d97674b3dab1.18085285</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F4F46340-924A-4974-8890-CFCF22714A88</gtr:id><gtr:title>Novel genotypes of H9N2 influenza A viruses isolated from poultry in Pakistan containing NS genes similar to highly pathogenic H7N3 and H5N1 viruses.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/77f3a963e90bc06648b07ce0dd4612f0"><gtr:id>77f3a963e90bc06648b07ce0dd4612f0</gtr:id><gtr:otherNames>Iqbal M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>414E541080F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CF95F4D8-0311-4F9D-A442-595FF0E454A6</gtr:id><gtr:title>Within-host variation of avian influenza viruses.</gtr:title><gtr:parentPublicationTitle>Philosophical transactions of the Royal Society of London. Series B, Biological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/77f3a963e90bc06648b07ce0dd4612f0"><gtr:id>77f3a963e90bc06648b07ce0dd4612f0</gtr:id><gtr:otherNames>Iqbal M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0962-8436</gtr:issn><gtr:outcomeId>2B28CB4ACA2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>072105CD-4007-4839-B321-A9E564DD2897</gtr:id><gtr:title>WHO recommendations for the viruses to be used in the 2012 Southern Hemisphere Influenza Vaccine: epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from February to September 2011.</gtr:title><gtr:parentPublicationTitle>Vaccine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0d3ac03788098acd909e11c6f45f15c2"><gtr:id>0d3ac03788098acd909e11c6f45f15c2</gtr:id><gtr:otherNames>Klimov AI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0264-410X</gtr:issn><gtr:outcomeId>pm_15873_23_22917957</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7BD8846F-BD9F-4F65-A507-2713DB15090A</gtr:id><gtr:title>Receptor binding by an H7N9 influenza virus from humans.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c5b7df65b73711afafabedbac73ca4cb"><gtr:id>c5b7df65b73711afafabedbac73ca4cb</gtr:id><gtr:otherNames>Xiong X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>pm_15873_23_23787694</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1AD8AB9B-77FD-4CA9-80A3-363DFDD01795</gtr:id><gtr:title>Quantifying transmission of highly pathogenic and low pathogenicity H7N1 avian influenza in turkeys.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/08f31a54a83b101b09fc432e86211ea3"><gtr:id>08f31a54a83b101b09fc432e86211ea3</gtr:id><gtr:otherNames>Saenz RA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_15873_23_23028760</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>914CFCEC-9F62-478C-B8BA-D35413C26649</gtr:id><gtr:title>The Npro product of classical swine fever virus and bovine viral diarrhea virus uses a conserved mechanism to target interferon regulatory factor-3.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5b5ec0ebcc691662b7092a6145fd67ae"><gtr:id>5b5ec0ebcc691662b7092a6145fd67ae</gtr:id><gtr:otherNames>Seago J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>287B171BC3D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7B424B3C-2EE8-45E2-955D-B67B8AE0C9B8</gtr:id><gtr:title>The characteristics and antigenic properties of recently emerged subclade 3C.3a and 3C.2a human influenza A(H3N2) viruses passaged in MDCK cells.</gtr:title><gtr:parentPublicationTitle>Influenza and other respiratory viruses</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/df1446d37ddbc9ae923008079c6a1ce3"><gtr:id>df1446d37ddbc9ae923008079c6a1ce3</gtr:id><gtr:otherNames>Lin Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1750-2640</gtr:issn><gtr:outcomeId>589ddd6674c169.54420402</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>39B42FC9-995A-4634-9397-D2F51E667238</gtr:id><gtr:title>Effects of egg-adaptation on receptor-binding and antigenic properties of recent influenza A (H3N2) vaccine viruses.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f9b8b81676e429cf9015a3b58b5620c0"><gtr:id>f9b8b81676e429cf9015a3b58b5620c0</gtr:id><gtr:otherNames>Parker L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>589ddd69466a31.89037653</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DAFE5C39-7650-4E5E-A896-715096C4654C</gtr:id><gtr:title>Global circulation patterns of seasonal influenza viruses vary with antigenic drift.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/71fafd4a0e8082523ed381695139b36e"><gtr:id>71fafd4a0e8082523ed381695139b36e</gtr:id><gtr:otherNames>Bedford T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>56d9767482b818.22047990</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>12C54569-C18B-49F5-B37E-B6CE923F2D99</gtr:id><gtr:title>Enhanced human receptor binding by H5 haemagglutinins.</gtr:title><gtr:parentPublicationTitle>Virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c5b7df65b73711afafabedbac73ca4cb"><gtr:id>c5b7df65b73711afafabedbac73ca4cb</gtr:id><gtr:otherNames>Xiong X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0042-6822</gtr:issn><gtr:outcomeId>5457a2421e0390.68430617</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>108C502D-60B2-474A-8E83-6A4EF4AD6B29</gtr:id><gtr:title>Evolution of the receptor binding properties of the influenza A(H3N2) hemagglutinin.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5360052184835a92de21a35704db22ac"><gtr:id>5360052184835a92de21a35704db22ac</gtr:id><gtr:otherNames>Lin YP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>pm_15873_23_23236176</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0173EA6F-8608-4E48-9909-2491C6795F03</gtr:id><gtr:title>A phospha-oseltamivir-biotin conjugate as a strong and selective adhesive for the influenza virus.</gtr:title><gtr:parentPublicationTitle>Bioorganic &amp; medicinal chemistry letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f7ad0c740df7f724753ca657f84a721"><gtr:id>8f7ad0c740df7f724753ca657f84a721</gtr:id><gtr:otherNames>Streicher H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0960-894X</gtr:issn><gtr:outcomeId>5457a24298b290.53656298</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U117585868</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>75</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>CDB856E6-DF2D-4D96-88BD-1CC96FE277EF</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.2  Factors relating to physical environment</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>